Abstract
Cannabidiol (CBD), the main nonpsychoactive constituent of Cannabis sativa, has shown a wide range of therapeutically promising pharmacological effects either as a sole drug or in combination with other drugs in adjunctive therapy. However, the targets involved in the therapeutic effects of CBD appear to be elusive. Furthermore, scarce information is available on the biological activity of its human metabolites which, when formed in pharmacologically relevant concentration, might contribute to or even account for the observed therapeutic effects. The present overview summarizes our current knowledge on the pharmacokinetics and metabolic fate of CBD in humans, reviews studies on the biological activity of CBD metabolites either in vitro or in vivo, and discusses relevant drug-drug interactions. To facilitate further research in the area, the reported syntheses of CBD metabolites are also catalogued.
| Original language | English |
|---|---|
| Pages (from-to) | 90-101 |
| Number of pages | 12 |
| Journal | Cannabis and Cannabinoid Research |
| Volume | 1 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jan 2016 |
Bibliographical note
Publisher Copyright:© István Ujváry and Lumír Hanuš 2016; Published by Mary Ann Liebert, Inc. 2016.
Keywords
- biological activity
- cannabidiol
- metabolites
- pharmacokinetics
- synthesis
